Showing 2061-2070 of 3315 results for "".
- Bausch + Lomb Launches Infuse Silicone Hydrogel (SIHY) Daily Disposable Contact Lenseshttps://modernod.com/news/bausch-lomb-launches-infuse-silicone-hydrogel-sihy-daily-disposable-contact-lenses/2478170/Bausch + Lomb announced the launch of Bausch + Lomb Infuse silicone hydrogel (SiHy) daily disposable contact lens. The Infuse lenses feature a next generation material infused with ProBalance Technology to help maintain ocular surface homeostasis and help reduce symptoms of contact lens dryness,
- Multifocal Contact Lenses With High Add Power Help Slow Myopia Progressionhttps://modernod.com/news/multifocal-contact-lenses-with-high-add-power-help-slow-myopia-progression/2478162/Soft multifocal contact lenses with a high add power help slow progression of myopia in children, more so than multifocal lenses with medium add power or single-vision lenses, according to results of the BLINK trial, Reuters reported.
- Health Canada Approves Bausch + Lomb Ultra One Day Silicone Hydrogel Daily Disposable Contact Lenseshttps://modernod.com/news/health-canada-approves-bausch-lomb-ultra-one-day-silicone-hydrogel-daily-disposable-contact-lenses/2478142/Bausch + Lomb announced that it has received approval from Health Canada for the sale of Bausch + Lomb Ultra One Day daily disposable silicone hydrogel (SiHy daily) contact lenses. Bausch + Lomb Ultra One Day contact lenses feature a next generation contact lens material (kalifilcon A) wit
- Alcon Canada introduces PRECISION1 Contact Lenseshttps://modernod.com/news/alcon-canada-introduces-precision1-contact-lenses/2478144/Alcon has launched the PRECISION1 daily disposable, silicone hydrogel (SiHy) contact lenses in Canada. Designed to address the common issues that cause 1-in-5 new wearers to discontinue contact lens within the first year (poor vision, comfort and handling issues1), Precision1 he
- At Least 97,000 Children Tested Positive For Coronavirus In Last 2 Weeks Of Julyhttps://modernod.com/news/at-least-97000-children-tested-positive-for-coronavirus-in-last-2-weeks-of-july-at-least-97000-children-tested-positive-for-the-coronavirus-during-the-last-two-weeks-of-july-according-to-a-new-revi/2478145/At least 97,000 children tested positive for the coronavirus during the last two weeks of July, according to a new review of state-level data by the Americ
- Gyroscope Announces Appointment of Leaders in Retinal Disease, Gene Therapy and the Complement System to Advisory Boardshttps://modernod.com/news/gyroscope-announces-appointment-of-leaders-in-retinal-disease-gene-therapy-and-the-complement-system-to-advisory-boards/2478130/Gyroscope Therapeutics announced the appointment of leading experts in retinal disease, gene therapy, and the complement system to its Clinical and Scientific advisory boards. The newly appointed boards will help guide the development of the company’s lead investigational gene therapy, GT00
- Bausch + Lomb Launches -2.75 Cylinder for Biotrue ONEday for Astigmatism Daily Disposable Contact Lenseshttps://modernod.com/news/bausch-lomb-launches-2-75-cylinder-for-biotrue-oneday-for-astigmatism-daily-disposable-contact-lenses/2478129/Bausch + Lomb announced the US launch of the -2.75 cylinder parameter offering for Biotrue ONEday for Astigmatism daily disposable contact lenses, the first and only toric daily disposable with a -2.75 cylinder. This new parameter offering will be available for same day fitting in a standard fit
- Hanita Lenses Announces Launch of Intensity IOLhttps://modernod.com/news/hanita-lenses-announces-launch-of-intensity-iol/2478082/After 3 years of development, Israel-based Hanita Lenses announced the launch of the Intensity IOL. The Intensity is a presbyopia-correcting IOL that has been developed by employing a proprietary iterative algorithm—called the Dynamic Light Utilization (DLU) technology—for better light eff
- Researchers Capture Cell-Level Details of Curved Corneahttps://modernod.com/news/researchers-capture-cell-level-details-of-curved-cornea/2478069/Researchers have, for the first time, acquired optical coherence tomography (OCT) images of the curved layers of a person’s cornea with cell-level detail and a large viewing area, according to a study in Optica. The new OCT instrument enables improved monitoring of eye diseases as well a
- Norlase Announces CE Mark Approval for LEAF Green Laserhttps://modernod.com/news/norlase-announces-ce-mark-approval-for-leaf-green-laser/2478045/Norlase announced that it has been granted the CE Mark approval for the LEAF, a first in class, fiberless green laser for the treatment of retina and glaucoma diseases. The CE Mark follows the recent FDA 510(k) market clearance of the LEAF and ISO 13485:2016 certification of Norlase’s medical dev